YAP1 and cancer: Finally, we identified five key EMT pathways dysregulated in CF cells and several proteins among the F508del-CFTR–specific YAP1 interactors, which emerge as major hubs possibly mediating the crosstalk among these pathways and appearing as potential therapeutic targets for both CF and cancer.